Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


27.03.2017

2 Am J Surg
5 Ann Oncol
3 Anticancer Res
1 Cancer Lett
4 Eur J Surg Oncol
1 Gut
2 Int J Cancer
1 Nat Rev Cancer
5 PLoS One
1 Proc Natl Acad Sci U S A
1 World J Surg


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. MANENTI A, Bonetti LR, Farinetti A, Sani F, et al
    The lymphatic anatomy of the mesorectum helps to understand rectal cancer recurrence.
    Am J Surg. 2016;212:800.
    PubMed     Text format    

  2. MARKL B, Schaller T, Kokot Y, Endhardt K, et al
    Lymph node size as a simple prognostic factor in node negative colon cancer and an alternative thesis to stage migration.
    Am J Surg. 2016;212:775-780.
    PubMed     Text format     Abstract available


    Ann Oncol

  3. FUCHS MA, Yuan C, Sato K, Niedzwiecki D, et al
    Predicted Vitamin D Status and Colon Cancer Recurrence and Mortality in CALGB 89803 (Alliance).
    Ann Oncol. 2017 Mar 15. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. PILATI C, Taieb J, Balogoun R, Marisa L, et al
    CDX2 prognostic value in stage II/III resected colon cancer is related to CMS classification.
    Ann Oncol. 2017 Feb 27. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. LONARDI S, Sobrero A, Rosati G, Di Bartolomeo M, et al
    Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial.
    Ann Oncol. 2017 Feb 23. doi: 10.1093.
    PubMed     Text format    

  6. LOTE H, Spiteri I, Ermini L, Vatsiou A, et al
    Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer.
    Ann Oncol. 2017 Feb 23. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. SANTINI D, Vincenzi B, Addeo R, Garufi C, et al
    Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
    Ann Oncol. 2017 Feb 21. doi: 10.1093.
    PubMed     Text format    


    Anticancer Res

  8. SEPAROVIC D, Shields AF, Philip PA, Bielawski J, et al
    Altered Levels of Serum Ceramide, Sphingosine and Sphingomyelin Are Associated with Colorectal Cancer: A Retrospective Pilot Study.
    Anticancer Res. 2017;37:1213-1218.
    PubMed     Text format     Abstract available

  9. FUJIKAWA H, Toiyama Y, Inoue Y, Imaoka H, et al
    Prognostic Impact of Preoperative Albumin-to-Globulin Ratio in Patients with Colon Cancer Undergoing Surgery with Curative Intent.
    Anticancer Res. 2017;37:1335-1342.
    PubMed     Text format     Abstract available

  10. YOON YS, Kim CW, Roh SA, Cho DH, et al
    Development and Applicability of Integrative Tumor Response Assays for Metastatic Colorectal Cancer.
    Anticancer Res. 2017;37:1297-1303.
    PubMed     Text format     Abstract available


    Cancer Lett

  11. KOUSTAS E, Karamouzis MV, Mihailidou C, Schizas D, et al
    Co-targeting of EGFR and autophagy signaling is an emerging treatment strategy in metastatic colorectal cancer.
    Cancer Lett. 2017 Mar 18. pii: S0304-3835(17)30197.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  12. ALAMRI Y, Buchwald P, Dixon L, Dobbs B, et al
    Salvage surgery in patients with recurrent or residual squamous cell carcinoma of the anus.
    Eur J Surg Oncol. 2016;42:1687-1692.
    PubMed     Text format     Abstract available

  13. HASEGAWA S, Takahashi R, Hida K, Kawada K, et al
    Revisiting the treatment strategy for rectal cancer through the pattern of local recurrence.
    Eur J Surg Oncol. 2016;42:1674-1679.
    PubMed     Text format     Abstract available

  14. MONASTYRSKA E, Hagner W, Jankowski M, Glowacka I, et al
    Prospective assessment of the quality of life in patients treated surgically for rectal cancer with lower anterior resection and abdominoperineal resection.
    Eur J Surg Oncol. 2016;42:1647-1653.
    PubMed     Text format     Abstract available

  15. ELLIOT AH, Martling A, Glimelius B, Johansson H, et al
    Impact of pre-treatment patient-related selection parameters on outcome in rectal cancer.
    Eur J Surg Oncol. 2016;42:1667-1673.
    PubMed     Text format     Abstract available


    Gut

  16. KINROSS J
    Race-specific differences in mucosal sulfidogenic bacteria modify colon cancer risk.
    Gut. 2017 Mar 20. pii: gutjnl-2017-313989. doi: 10.1136/gutjnl-2017-313989.
    PubMed     Text format    


    Int J Cancer

  17. ZHANG L, Li L, Gao G, Wei G, et al
    Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress.
    Int J Cancer. 2017 Mar 17. doi: 10.1002/ijc.30698.
    PubMed     Text format     Abstract available

  18. ZHU XH, Wang JM, Yang SS, Wang FF, et al
    Down-regulation of DAB2IP promotes colorectal cancer invasion and metastasis by translocating hnRNPK into nucleus to enhance the transcription of MMP2.
    Int J Cancer. 2017 Mar 23. doi: 10.1002/ijc.30701.
    PubMed     Text format     Abstract available


    Nat Rev Cancer

  19. DIENSTMANN R, Vermeulen L, Guinney J, Kopetz S, et al
    Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer.
    Nat Rev Cancer. 2017;17:268.
    PubMed     Text format    


    PLoS One

  20. SIMICZYJEW A, Mazur AJ, Dratkiewicz E, Nowak D, et al
    Involvement of beta- and gamma-actin isoforms in actin cytoskeleton organization and migration abilities of bleb-forming human colon cancer cells.
    PLoS One. 2017;12:e0173709.
    PubMed     Text format     Abstract available

  21. HUANG WY, Ho CL, Lee CC, Hsiao CW, et al
    Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer.
    PLoS One. 2017;12:e0174280.
    PubMed     Text format     Abstract available

  22. YANG M, Xiao X, Xing X, Li X, et al
    KRAS and VEGF gene 3'-UTR single nucleotide polymorphisms predicted susceptibility in colorectal cancer.
    PLoS One. 2017;12:e0174140.
    PubMed     Text format     Abstract available

  23. WIEGERING A, Riegel J, Wagner J, Kunzmann V, et al
    The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases.
    PLoS One. 2017;12:e0173933.
    PubMed     Text format     Abstract available

  24. BERGER AW, Schwerdel D, Welz H, Marienfeld R, et al
    Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA.
    PLoS One. 2017;12:e0174308.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  25. LI C, Singh B, Graves-Deal R, Ma H, et al
    Three-dimensional culture system identifies a new mode of cetuximab resistance and disease-relevant genes in colorectal cancer.
    Proc Natl Acad Sci U S A. 2017 Mar 20. pii: 201618297.
    PubMed     Text format     Abstract available


    World J Surg

  26. LEE JH, Lee JL, Kim JC
    Identification of Recurrence-Predictive Indicators in Stage I Colorectal Cancer: Reply.
    World J Surg. 2017 Mar 20. doi: 10.1007/s00268-017-3994.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: